We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Detection of Human Cytomegalovirus in the Saliva (FcrèchMV)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00815802
Recruitment Status : Completed
First Posted : December 30, 2008
Last Update Posted : December 30, 2008
Sponsor:
Information provided by:

Study Description
Brief Summary:

Direct DNA amplification, viral isolation and specific antibody measurement in saliva

  1. From children in day care centers (samples collection will take place during a single week)
  2. From children coming at the emergency department of our hospital during a three months period.

Sample collection will be done by the pediatrician the nurse, or one of the authorized investigators of the study.


Condition or disease
Cytomegalovirus

Detailed Description:
Salivary collection kit. Collection of salivary at the internal face of the mooth. 3 swab for DNA research, 1 for antibodies research and 1 for virus isolation by cell growth.

Study Design

Study Type : Observational
Actual Enrollment : 655 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Detection of Human Cytomegalovirus in the Saliva of 3 Month to 6 Year-Old Children in Day Care Centers : a Pilot Study.
Study Start Date : July 2007
Groups and Cohorts


Outcome Measures

Primary Outcome Measures :
  1. One week trial of saliva sampling for cytomegalovirus detection in day-care centers.

Secondary Outcome Measures :
  1. Percentage of chidrens with CMV excretion among those coming at the Emergency department of Limoges teacher Hospital (CHU). Validation of the process from samples collection to interpretation of results

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   3 Months to 6 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
child aged from 3 month to 6 years in day care centers or in emergency department.
Criteria

Inclusion Criteria:

  • parents consent
  • child aged from 3months to 6 years
  • child in day care centers or emergency department

Exclusion Criteria:

  • Refuse of participation
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00815802


Locations
France
Bactériologie-Virologie
Limoges, France, 87
Sponsors and Collaborators
University Hospital, Limoges
Investigators
Principal Investigator: Sophie ALAIN, MD University Hospital, Limoges
More Information

ClinicalTrials.gov Identifier: NCT00815802     History of Changes
Other Study ID Numbers: I07017
First Posted: December 30, 2008    Key Record Dates
Last Update Posted: December 30, 2008
Last Verified: December 2008

Keywords provided by University Hospital, Limoges:
Children in day care centers
cytomegalovirus excretion